Literature DB >> 11408931

Reduced expression of REIC/Dkk-3 gene in non-small cell lung cancer.

I Nozaki1, T Tsuji, O Iijima, Y Ohmura, A Andou, M Miyazaki, N Shimizu, M Namba.   

Abstract

Dickkopfs (Dkks) are secretory glycoproteins and are important for inducing amphibian head formation. Some Dkks have the ability to antagonize the Wnt proto-oncoprotein, which can promote cell proliferation and transformation when it is mutated or overexpressed. We recently cloned the REIC/Dkk-3 gene, one of the Dkks, and found that expression of the gene was markedly decreased in many human immortalized and tumor-derived cell lines. To further investigate the function of the REIC/Dkk-3 gene in vivo, the gene expression was quantified in 57 surgically-resected non-small cell lung cancer (NSCLC) tissues and their adjacent normal lung tissues by real-time quantitative PCR analysis based on TaqMan methodology. The REIC/Dkk-3 mRNA level was significantly lower in NSCLC tissues than in normal lung tissues. Reduced expression of REIC/Dkk-3 in NSCLC was observed in 36 (63%) of the 57 tumors. Reduced expression of REIC/Dkk-3 was frequently observed in poorly differentiated adenocarcinoma and squamous cell carcinoma. These results indicate that reduced expression of REIC/Dkk-3 may be correlated with rapid cell proliferation in human NSCLC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408931     DOI: 10.3892/ijo.19.1.117

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  41 in total

1.  Expression of the Wnt antagonist DKK3 is frequently suppressed in sporadic epithelial ovarian cancer.

Authors:  An You; Emmanouil Fokas; Lin-Fang Wang; Haitao He; Beate Kleb; Dieter Niederacher; Rita Engenhart-Cabillic; Han-Xiang An
Journal:  J Cancer Res Clin Oncol       Date:  2010-06-09       Impact factor: 4.553

2.  Distinct gene expression profile of human mesenchymal stem cells in comparison to skin fibroblasts employing cDNA microarray analysis of 9600 genes.

Authors:  Cornelia Brendel; Larissa Kuklick; Oliver Hartmann; Theo Daniel Kim; Ulrich Boudriot; Dagmar Schwell; Andreas Neubauer
Journal:  Gene Expr       Date:  2005

3.  Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.

Authors:  Thanh H Dellinger; Kestutis Planutis; Danielle D Jandial; Ramez N Eskander; Micaela E Martinez; Xiaolin Zi; Bradley J Monk; Randall F Holcombe
Journal:  Gynecol Oncol       Date:  2012-04-30       Impact factor: 5.482

4.  Immunohistochemically detectable dickkopf-3 expression in tumor vessels predicts survival in gastric cancer.

Authors:  Gilbert Mühlmann; Gerold Untergasser; Matthias Zitt; Marion Zitt; Hans Maier; Gregor Mikuz; Irmgard E Kronberger; Michael C Haffner; Eberhard Gunsilius; Dietmar Ofner
Journal:  Virchows Arch       Date:  2010-05-15       Impact factor: 4.064

5.  Tumor-induced osteomalacia.

Authors:  Emily G Farrow; Kenneth E White
Journal:  Expert Rev Endocrinol Metab       Date:  2009-09-01

6.  Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma.

Authors:  Liran Zhou; Hongmei Husted; Todd Moore; Mason Lu; Defeng Deng; Yan Liu; Vijaya Ramachandran; Thiruvengadam Arumugam; Christof Niehrs; Huamin Wang; Paul Chiao; Jianhua Ling; Michael A Curran; Anirban Maitra; Mien-Chie Hung; Jeffrey E Lee; Craig D Logsdon; Rosa F Hwang
Journal:  Sci Transl Med       Date:  2018-10-24       Impact factor: 17.956

7.  Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro.

Authors:  Yu-Mei Gu; Yi-Hui Ma; Wu-Gan Zhao; Jie Chen
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

8.  Folate-receptor 1 (FOLR1) protein is elevated in the serum of ovarian cancer patients.

Authors:  F Leung; A Dimitromanolakis; H Kobayashi; E P Diamandis; V Kulasingam
Journal:  Clin Biochem       Date:  2013-03-23       Impact factor: 3.281

9.  Novel REIC/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer.

Authors:  H Sawahara; H Shiraha; D Uchida; H Kato; T Nagahara; M Iwamuro; J Kataoka; S Horiguchi; M Watanabe; M Sakaguchi; A Takaki; K Nouso; Y Nasu; H Kumon; H Okada
Journal:  Cancer Gene Ther       Date:  2016-07-29       Impact factor: 5.987

10.  Overexpression of REIC/Dkk-3 in normal fibroblasts suppresses tumor growth via induction of interleukin-7.

Authors:  Masakiyo Sakaguchi; Ken Kataoka; Fernando Abarzua; Ryuta Tanimoto; Masami Watanabe; Hitoshi Murata; Swe Swe Than; Kaoru Kurose; Yuji Kashiwakura; Kazuhiko Ochiai; Yasutomo Nasu; Hiromi Kumon; Nam-ho Huh
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.